Tradolan retard 100 mg - Filmtabletten
Recall
|
Medicines
|
13/05/2022
The marketing authorisation holder informed its customers on May 12, 2022, that it cannot be excluded that the package of the medicinal product „Tradolan retard 100 mg – Filmtabletten“ contains the non-related patient information leaflet of the medicinal product „Mirtel 30 mg – Filmtabletten“.
It is assumed that the information regarding intake, side effects and dosage of the prescription medicine is discussed with the attending physician.
The affected batch is recalled as a precaution.
| Name of the medicinal product | Tradolan retard 100 mg - Filmtabletten |
|---|---|
| Marketing authorisation number(s) | 1-21255 |
| CIP code | 1347409 |
| Marketing authorisation holder | G.L. Pharma GmbH |
| Batch number(s) | E08226 |
| Expiry date | 04/30/2025 |
| Classification of the recall | 2 |
| Depth of recall | Pharmacies |
| BASG reference number | INS-640.001-3855 |
Further inquiry note
Page last modified:
13/05/2022